Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1536 of 6351
-
New AI tool could revolutionize male fertility testing for IVF
Diagnosis Not yet recruitingInfertility is a growing global health problem affecting millions of couples worldwide, with male infertility accounting for approximately half of all cases. In the physiological environment, sperm go through an exhaustive selection process in the female reproductive tract before…
Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
VR therapy takes on social anxiety in youth
Symptom relief Not yet recruitingThis randomized controlled trial evaluates the effectiveness of a VR-based CBT intervention for social anxiety-driven depression among Hong Kong youth (ages 15-24). Given the limitations of traditional CBT in addressing deep-seated fears, this study explores a more engaging and s…
Sponsor: Hong Kong Shue Yan University • Aim: Symptom relief
Last updated Jun 26, 2026 17:06 UTC
-
Virtual reality rehab at home could transform stroke recovery
Symptom relief Not yet recruitingStroke is the leading cause of disability in adults worldwide. Rehabilitation after a stroke is crucial, even after the acute phase: initially, it aims to recover the deficits caused by the stroke, but in the subacute/chronic phases the objective is to maintain the functional abi…
Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
New injectable drug hopes to boost heart function in PAH patients
Disease control Not yet recruitingPulmonary Arterial Hypertension (PAH) is a serious condition that puts strain on the right side of the heart. While oral medications can help, many patients with intermediate-risk PAH may not see enough improvement, and their heart function can continue to decline. This study ai…
Phase 2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 26, 2026 18:35 UTC
-
Can a phone app improve depression care?
Symptom relief Recruiting nowMood disorders like depression and bipolar disorder are widespread and cause serious psychological, cognitive, and social impairments, with a high burden on healthcare systems. Edra PRO is a digital medical device developed to support clinical decision-making and remotely monitor…
Sponsor: Resilience • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New cocktail aims to stop Chemo-Induced sickness in stem cell transplants
Symptom relief Recruiting nowThis study employs a prospective, multicenter, randomized, two-arm design aimed at evaluating the efficacy and safety of the FTO regimen in preventing delayed chemotherapy-induced nausea and vomiting (CINV) following high-dose chemotherapy for hematopoietic stem cell transplantat…
Phase 3 • Sponsor: The Affiliated People's Hospital of Ningbo University • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New drug combo aims to keep advanced lung cancer in check
Disease control Recruiting nowThis is an open-label, single-arm, phase 2 study to evaluate the safety and efficacy of golidocitinib with PD-1 inhibitors as maintenance treatment in patients with previously untreated extensive-stage small cell lung cancer.
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Could a Once-a-Year cholera shot be just as good?
Vaccine Recruiting nowBackground: Despite efforts to control cholera, outbreaks continue to occur in Kenya. Oral cholera vaccines (OCVs) are a critical tool in cholera prevention strategies. This study evaluates the immunogenicity of extended dosing intervals for Euvichol-S, a WHO-prequalified OCV, in…
Phase 4 • Sponsor: Albert B. Sabin Vaccine Institute • Aim: Vaccine
Last updated Jun 27, 2026 12:00 UTC
-
AI reads your face to keep brain training on track
Disease control Recruiting nowHow to ensure adherence to computerized cognitive training in unsupervised circumstances (e.g., at-home, self-administered) in older adults at risk for Alzheimer's disease (AD) or AD related dementia (AD/ADRD) is understudied. The objective of the R33 study is to test a novel fac…
Phase 1/2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a pill prevent dangerous platelet drops during breast cancer treatment?
Disease control Not yet recruitingAdo-trastuzumab emtansine (T-DM1) demonstrates favorable efficacy in breast cancer treatment but is frequently associated with thrombocytopenia. Multiple studies indicate that Asian populations face a higher risk of developing thrombocytopenia during T-DM1 therapy, with incidence…
Sponsor: Zhenzhen Liu • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can an 8-Week online course stop depression before it starts?
Prevention Recruiting nowThe present study aims to pilot internet-delivered Skills Training in Affective and Interpersonal Regulation (i-STAIR) as a transdiagnostic emotion dysregulation intervention to prevent progression to depression in individuals with adverse childhood experiences (ACEs) and subsynd…
Sponsor: Institute of Mental Health, Singapore • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
New stroke drug HRS-7450 enters Mid-Stage trial
Disease control OngoingThis study plans to enroll a total of 208 patients with Acute Ischemic Stroke (AIS) who present within 4.5 to 24 hours of symptom onset and meet the specified imaging criteria.
Phase 2 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New hope for painful skin condition: experimental drug CIT-013 enters Mid-Stage trial
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if CIT-013 works to treat Hidradenitis Suppurativa in adults. It will also learn about the safety of CIT-013. The main questions it aims to answer are: Does CIT-013 lower the disease activity of HS patients? What medical problems do pa…
Phase 2 • Sponsor: Citryll BV • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Brain catcher: new device may prevent stroke during heart procedure
Disease control Recruiting nowThis is a prospective, multi-center, randomized controlled study. The goal of the study is to assess the safety and effectiveness of the Resonova® CHORDS® Cerebral Protection System in capturing and removing embolic debris during Transcatheter Aortic Valve Replacement (TAVR). A t…
Sponsor: Resonova (Shanghai) Medtech Limited • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental CAR-T therapy takes aim at tough blood cancers
Disease control Not yet recruitingA Clinical Study to Explore the Safety, Efficacy and Cellular Metabolic Kinetics of CT1194D CAR-T Cells Injection in Patients with Relapsed/Refractory B-Cell Neoplasms
Phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Immune-Guided drug timing could cut CMV prevention after transplant
Prevention Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of a personalized strategy for discontinuing Letermovir (a drug used to prevent Cytomegalovirus \[CMV\] infection) based on the recovery of the patient's own immune system. Cytomegalovirus (CMV) is a common and ser…
Phase 4 • Sponsor: WeiShi • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
New dressing aims to speed healing of diabetic foot ulcers
Disease control Recruiting nowProspective, multi-centered, observer blinded, pre-market study, 1:1 randomized control trial, to determine if addition of EDX110 dressing system to standard of care leads to an improvement in diabetic foot ulcers healing compared to just using standard of care.
Sponsor: ConvaTec Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Exercise and diet may tame atrial fibrillation in overweight patients
Disease control Recruiting nowAtrial fibrillation (AF) is the most common cardiac arrhythmia and is strongly associated with obesity and excess body fat. Lifestyle interventions, including exercise and dietary modification, may reduce AF burden, but long-term randomized controlled trial evidence with objectiv…
Sponsor: University of Eastern Finland • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New pain plan could cut opioid use in Kids' spine surgery
Symptom relief Recruiting nowThe multicenter PRECISE Analgesia (Prospective Randomized Evaluation of Analgesia for Idiopathic Scoliosis Spine Fusion Elective Surgery in Children) trials will a) implement and investigate the efficacy and safety of multidose methadone-based standardized enhanced recovery after…
Phase 3 • Sponsor: Senthil Sadhasivam • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Cholesterol drug tested to stop stroke worsening
Disease control CompletedThis study is a Phase IIa clinical trial initiated by the researchers, which is prospective, single-center, randomized, open-label, with blinded endpoint evaluation (PROBE design). Patients were screened through the emergency stroke green channel and included if they had an onset…
Phase 4 • Sponsor: The Affiliated Hospital of Xuzhou Medical University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC